Interventional Spine, Inc. announced FDA clearance of the 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device, indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1.
This device joins the Interventional Spine family of Opticage™ Expandable Interbody Fusion implants cleared in 4Q15, and can also be used with the company’s PerX360 System™.
Interventional Spine, Inc. announced FDA clearance of the 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device, indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1.
This device joins the Interventional Spine family of Opticage™ Expandable...
Interventional Spine, Inc. announced FDA clearance of the 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device, indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1.
This device joins the Interventional Spine family of Opticage™ Expandable Interbody Fusion implants cleared in 4Q15, and can also be used with the company’s PerX360 System™.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.